Concepedia

Agnès Amador

AA

Statistics

Publications

7

Citations

496

H-Index

7

Active since

2006

Affiliations

Idera Pharmaceuticals (United States)(Current)

Université de Montpellier

Merck & Co., Inc., Rahway, NJ, USA (United States)

Centre National de la Recherche Scientifique

Agnès Amador is an author at Idera Pharmaceuticals (United States) specializing in drug discovery, medicinal chemistry, and antiviral structure-activity relationships.

Publications per year

2006–2018

7

Publications

7

Synthesis and Pharmacokinetics of Valopicitabine (NM283), an Efficient Prodrug of the Potent Anti-HCV Agent 2‘-<i>C</i>-Methylcytidine

Claire Pierra, Agnès Amador, S. Benzaria et al. · Journal of Medicinal Chemistry · 2006 · 189 citations · Full text

, , +17

Synthesis and Biological Evaluation of Aryl-phospho-indole as Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors

François-René Alexandre, Agnès Amador, Stéphanie Bot et al. · Journal of Medicinal Chemistry · 2010 · 179 citations

, , +17

Discovery of the Aryl-phospho-indole IDX899, a Highly Potent Anti-HIV Non-nucleoside Reverse Transcriptase Inhibitor

Cyril B. Dousson, François-René Alexandre, Agnès Amador et al. · Journal of Medicinal Chemistry · 2016 · 73 citations

, , +17

Synthesis of 2'-C-Methylcytidine and 2'-C-Methyluridine Derivatives Modified in the 3'-Position as Potential Antiviral Agents

Claire Pierra, Agnès Amador, Eric Badaroux et al. · Collection of Czechoslovak Chemical Communications · 2006 · 19 citations

, , +17

Synthesis of potent and broad genotypically active NS5B HCV non-nucleoside inhibitors binding to the thumb domain allosteric site 2 of the viral polymerase

Claire Pierra Rouvière, Agnès Amador, Eric Badaroux et al. · Bioorganic & Medicinal Chemistry Letters · 2016 · 13 citations · Full text

, , +16

1–5 of 7